Watch Demo

Norway Antidepressant Industry Outlook 2022 - 2026

See how Norway Antidepressant performed compared to key markets such as Canada, Germany and Spain.

Key Market Indicators

Sales of antidepressant medications in Norway are estimated to drop to $22.54 million by 2026, a decrease of 5.3% from 2021's total of $31.92 million. This trend reverses the steady growth seen since 2007, when the Norwegian market was up 0.1% year on year. In 2021, Norway was the 16th-largest market for antidepressant medications, with Finland overtaking it at $31.92 million. Germany, Spain and Italy ranked second, third, and fourth, respectively.

Marketing Banner

Norway Antidepressant Market Data and Forecasts

How much will Norway Antidepressant Market grow to 2026?

Forecast: Anxiolytic Medicine Sales in Norway
Forecast: Antidepressant Medicine Sales in Norway
Forecast: Antidepressant Medicine Sales in Norway
Forecast: Anxiolytic Medicine Sales in Norway
Forecast: Antidepressant Medicine Sales in Norway
More in Antidepressant Industry for 2028